Vinorelbine is a chemotherapy drug marketed under the name Navelbine; it is most often used to treat
ovarian cancer. It is a Vinca alkaloid and is a semisynthetic derivative of vinblastine. It appears as a pale yellow fluid and is administered intravenously. The side effects of this drug include diarrhea, nausea, and hair loss; it seems to be less of a nerve poison than vindesine.